esmolol has been researched along with Infections, Pseudomonas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allaouchiche, B; Ayoub, JY; Bonnet-Garin, JM; Boselli, E; Bouvet, L; Dauwalder, O; Jacquet-Lagrèze, M; Junot, S; Mansour, C; Margez, T; Paquet, C; Restagno, D | 1 |
Armaganidis, A; Dimopoulos, G; Giamarellos-Bourboulis, EJ; Lignos, M; Theodorakopoulou, M; Tsaganos, T; Tzepi, IM | 1 |
1 trial(s) available for esmolol and Infections, Pseudomonas
Article | Year |
---|---|
Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cardiac Output; Cardiopulmonary Resuscitation; Heart Rate; Hemodynamics; Monitoring, Physiologic; Nociception; Propanolamines; Prospective Studies; Pseudomonas Infections; Random Allocation; Shock, Septic; Swine; Swine Diseases | 2018 |
1 other study(ies) available for esmolol and Infections, Pseudomonas
Article | Year |
---|---|
Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunologic Factors; Male; Malondialdehyde; Propanolamines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits | 2015 |